Patent Term Extended Under 35 U.S.C.   156(d)(5)

   An order granting a one-year interim extension of the term of the
following patent was granted on April 7, 1997.

   U.S. Patent No. 4,197,297; Granted June 13, 1989, to Joseph Weinstock;
Owner of Record: SmithKline Beecham Corporation; Title: 6-Halo-7,8-Dihy-
droxy-1-(Hydroxyphenyl)-2,3,4,5-Tetrahydro-1H-3-Benzazepines; Classifica-
tion: 514/213; Product Name: CORLOPAM ; Active Ingredient: Fenoldopam
Mesylate; Original Expiration Date: April 8, 1997;  Term Extended: One
Year; Extended Expiration Date: April 8, 1998.


                  Patent Term Extended Under 35 U.S.C.   156

   A certificate extending the term of the following patent was issued on
April 4, 1997.

   U.S. Patent No. 4,839,342; Granted June 13, 1989, to Renee Kaswan; Owner
of Record: University of Georgia Research Foundation, Inc.; Title:
Method of Increasing Tear Production by Topical Administration of
Cyclosporin; Classification: 514/256; Product Trade Name: OPTIMMUNE ;
Original Expiration Date: September 2, 2007; Term Extended: 700 days;
Extended Expiration Date: August 2, 2009.